Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice.
about
Gut microbiota and metabolic syndromeThe Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular DiseaseThe Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic BackgroundGut Microbiota and Lifestyle Interventions in NAFLDType 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the SpotlightDiet, Microbiota, Obesity, and NAFLD: A Dangerous QuartetGut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of MetabolomicsChemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agentsOvernutrition Determines LPS Regulation of Mycotoxin Induced Neurotoxicity in Neurodegenerative DiseasesThe gut microbiota and host health: a new clinical frontierHuman microbiome: From the bathroom to the bedsideNovel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and developmentThe role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver diseaseInsulin resistance in clinical and experimental alcoholic liver diseaseDiscovering probiotic microorganisms: in vitro, in vivo, genetic and omics approachesCo-Administration of Cholesterol-Lowering Probiotics and Anthraquinone from Cassia obtusifolia L. Ameliorate Non-Alcoholic Fatty LiverCystic fibrosis related liver disease--another black box in hepatology.The microbial-mammalian metabolic axis: a critical symbiotic relationshipHypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease.Microbiota Is Involved in Post-resection Adaptation in Humans with Short Bowel Syndrome.The Possible Role of Helicobacter pylori Infection in Non-alcoholic Fatty Liver Disease.Modulation of the Gut Microbiota by Krill Oil in Mice Fed a High-Sugar High-Fat DietSaccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db mice.Fecal microbiota transplantation in metabolic syndrome: History, present and future.Developmental origins of nonalcoholic fatty liver diseaseMicrobiota-liver axis in hepatic disease.The gut microbiota: a major player in the toxicity of environmental pollutants?Mechanistic links between gut microbial community dynamics, microbial functions and metabolic healthFecal microbiota transplantation broadening its application beyond intestinal disorders.Harnessing the beneficial properties of adipogenic microbes for improving human health.Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease.Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice.Implication of gut microbiota in nonalcoholic fatty liver disease.Gut microbiome and metabolic diseases.Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease.Meta-omic platforms to assist in the understanding of NAFLD gut microbiota alterations: tools and applications.Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver diseaseIntestinal microbiota in metabolic diseases: from bacterial community structure and functions to species of pathophysiological relevance.Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.Dietary trans-10, cis-12-conjugated linoleic acid alters fatty acid metabolism and microbiota composition in mice.
P2860
Q24563886-3FEA00F5-9E07-4F44-8D5F-AB75C769C0EAQ26739993-0BFC19EA-BF7B-4196-891B-2395AAE4B528Q26744380-EE74BE46-5B4B-48FA-8B23-EE5DEA9DDAEBQ26749783-FC2C423A-547A-4EEF-B454-6213F0027E25Q26752583-7EE9F515-D79D-48EA-84F9-C7B997169D4DQ26752614-7974668B-0CE2-4C61-9D9C-6C3270CD45F6Q26753047-51D0AB71-6C28-4A1D-BBAC-C75CC6D95D75Q26772302-C2491F19-60B1-45A8-8409-07D7DB9934D1Q26774272-75B4D78B-568E-4639-AE46-D9D2AD9EB4F4Q26785649-C5204D01-2071-4A7D-A339-8835B4EF5BB4Q26795386-BE3E8C5A-E82B-4F84-85B3-D8F791492557Q26851211-7782CED7-1F71-4F15-A04D-5F55B53441F1Q26852498-920D5772-B1AE-4726-B396-18C7FB8E3D3CQ26865988-E0035E03-32C7-460F-B0E2-DDC462D5EBA9Q27012682-C37A1026-E51D-4183-9419-90CD4D363D8BQ27317549-295A7324-155D-4F5C-A355-2680FC9BC1B3Q28655881-7C2B1487-79CE-4731-BE1A-2C131F3D43AAQ28828859-30C65729-2AC8-4BAB-B732-AB13E8176213Q30251565-E408617C-B176-46E8-BD5C-A518DFC10A4AQ33575682-7BB0F7B4-7008-4CB8-BF8C-E8FACEACFA72Q33653828-926FF6A8-E3A3-4CF4-BB00-1532671E2AEEQ33695218-6E0E5EAF-8324-49FC-80E8-EB6C42D5C12FQ33751828-C4825554-7E3D-4BA3-996A-877C2DBF2F68Q33821397-89CAB9CA-FFBA-4776-BFD6-EBCF7F8964B0Q33844787-ED1A97A0-B009-4AAC-AF7E-C589AA0662B1Q33855414-E7369571-09A3-4904-9ED3-2645CFF0078AQ33914916-16483150-5645-401E-80AA-BD8E32E13485Q34589695-15E538C7-3C7B-4695-995F-6C7D89691C71Q34667433-2A4CE3F0-B1A9-471E-A75D-960E95B6FC31Q34714843-CEFBF913-60AC-4DD8-B79D-C41E349F12F1Q34750494-3450AEE1-B348-4442-A944-8A615BECFF3AQ34760466-7B6212C6-EA9D-4892-8E1D-681D2FFFB30CQ35019282-5E7B63D5-01FE-4953-8F0A-57DC4F5F126AQ35033105-179AEA68-49C7-47F0-82FC-530A8A2E5162Q35040827-DC2611BA-E356-44EB-BA29-3EDF19352838Q35084719-A4E7DD34-71E0-4DD1-B739-377D7B11D335Q35174451-B93C6C7F-BF49-4F26-84E2-426C1938DA6AQ35202957-84E15FEF-9960-4C55-9B1A-C064677BE37FQ35242565-85A48C22-6699-4E42-834D-653B9B86DA80Q35564160-279152AB-21E0-4FAC-8135-B0DEBCCFEF53
P2860
Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Intestinal microbiota determin ...... c fatty liver disease in mice.
@ast
Intestinal microbiota determin ...... c fatty liver disease in mice.
@en
Intestinal microbiota determin ...... c fatty liver disease in mice.
@nl
type
label
Intestinal microbiota determin ...... c fatty liver disease in mice.
@ast
Intestinal microbiota determin ...... c fatty liver disease in mice.
@en
Intestinal microbiota determin ...... c fatty liver disease in mice.
@nl
prefLabel
Intestinal microbiota determin ...... c fatty liver disease in mice.
@ast
Intestinal microbiota determin ...... c fatty liver disease in mice.
@en
Intestinal microbiota determin ...... c fatty liver disease in mice.
@nl
P2093
P50
P1433
P1476
Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice
@en
P2093
André Bado
Aurélia Bruneau
Catherine Philippe
Claudia Bevilacqua
Francine Walker
Gabriel Perlemuter
Patrice Martin
P304
P356
10.1136/GUTJNL-2012-303816
P407
P577
2012-11-29T00:00:00Z